<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
    <PublisherImprintName>Humana Press</PublisherImprintName>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
      <SeriesSubTitle Language="En">Methods and Protocols</SeriesSubTitle>
      <SeriesAbbreviatedTitle>Methods Molecular Biology</SeriesAbbreviatedTitle>
    </SeriesInfo>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
        <BookID>978-1-60327-931-4</BookID>
        <BookTitle>Neural Cell Transplantation</BookTitle>
        <BookSubTitle>Methods and Protocols</BookSubTitle>
        <BookVolumeNumber>549</BookVolumeNumber>
        <BookSequenceNumber>549</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-931-4</BookDOI>
        <BookTitleID>160368</BookTitleID>
        <BookPrintISBN>978-1-60327-930-7</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-931-4</BookElectronicISBN>
        <BookEdition>1</BookEdition>
        <BookChapterCount>16</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Code="L" Type="Primary">Life Sciences</BookSubject>
          <BookSubject Code="L16008" Priority="1" Type="Secondary">Cell Biology</BookSubject>
          <BookSubject Code="L16010" Priority="2" Type="Secondary">Stem Cells</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>David</GivenName>
              <FamilyName>Gordon</FamilyName>
            </EditorName>
            <Contact>
              <Email>d.gordon@bristol.ac.uk</Email>
            </Contact>
          </Editor>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>Neil J.</GivenName>
              <FamilyName>Scolding</FamilyName>
            </EditorName>
            <Contact>
              <Phone>+440177918-6632</Phone>
              <Email>n.j.scolding@tesco.net</Email>
            </Contact>
          </Editor>
          <Affiliation ID="AffID1">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="AffID2">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <Part ID="Part2">
        <PartInfo OutputMedium="All" TocLevels="0">
          <PartID>2</PartID>
          <PartSequenceNumber>2</PartSequenceNumber>
          <PartTitle> Practical/Methodological Chapters</PartTitle>
          <PartChapterCount>13</PartChapterCount>
          <PartContext>
            <SeriesID>7651</SeriesID>
            <BookID>978-1-60327-931-4</BookID>
            <BookTitle>Neural Cell Transplantation</BookTitle>
          </PartContext>
        </PartInfo>
        <Chapter ID="Chap15" Language="En">
          <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
            <ChapterID>15</ChapterID>
            <ChapterNumber>15</ChapterNumber>
            <ChapterDOI>10.1007/978-1-60327-931-4_15</ChapterDOI>
            <ChapterSequenceNumber>15</ChapterSequenceNumber>
            <ChapterTitle Language="En">Identifying Neural Progenitor Cells in the Adult Brain</ChapterTitle>
            <ChapterFirstPage>217</ChapterFirstPage>
            <ChapterLastPage>230</ChapterLastPage>
            <ChapterCopyright>
              <CopyrightHolderName>Humana Press, a part of Springer Science+Business Media, LLC</CopyrightHolderName>
              <CopyrightYear>2009</CopyrightYear>
            </ChapterCopyright>
            <ChapterHistory>
              <RegistrationDate>
                <Year>2009</Year>
                <Month>1</Month>
                <Day>5</Day>
              </RegistrationDate>
              <OnlineDate>
                <Year>2009</Year>
                <Month>3</Month>
                <Day>23</Day>
              </OnlineDate>
            </ChapterHistory>
            <ChapterGrants Type="Regular"><MetadataGrant Grant="OpenAccess"/><AbstractGrant Grant="OpenAccess"/><BodyPDFGrant Grant="Restricted"/><BodyHTMLGrant Grant="Restricted"/><BibliographyGrant Grant="Restricted"/><ESMGrant Grant="Restricted"/></ChapterGrants><ChapterContext>
              <SeriesID>7651</SeriesID>
              <PartID>2</PartID>
              <BookID>978-1-60327-931-4</BookID>
              <BookTitle>Neural Cell Transplantation</BookTitle>
            </ChapterContext>
          </ChapterInfo>
          <ChapterHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1_15">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Stephen</GivenName>
                  <FamilyName>Kelly</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_15">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Maeve</GivenName>
                  <FamilyName>Caldwell</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_15">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Matthew</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Keasey</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_15">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jessica</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Cooke</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_15" CorrespondingAffiliationID="Aff1_15">
                <AuthorName DisplayOrder="Western">
                  <GivenName>James</GivenName>
                  <GivenName>B.</GivenName>
                  <FamilyName>Uney</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>james.uney@bristol.ac.uk</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1_15">
                <OrgDivision>Clinical Sciences at South Bristol, Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology (LINE)</OrgDivision>
                <OrgName>University of Bristol</OrgName>
                <OrgAddress>
                  <Street>Dorothy Hodgkin Building</Street>
                  <City>Bristol</City>
                  <Postcode>BS1 3NY</Postcode>
                  <Country>UK</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1_15" Language="En" OutputMedium="All">
              <Heading>Summary</Heading>
              <Para>There is incontrovertible evidence that neural progenitor cells (NPC) are found in the adult brain. The ability to identify and track NPC in the adult brain is of considerable importance if the properties of these cells are to be harnessed as potential therapies for degenerative brain disorders. The most commonly used approach of identifying these NPC in experimental studies, bromodeoxyuridine (BrdU) labelling, is outlined in this chapter. Immunohistochemical protocols for detecting endogenous and exogenous (introduced via transplantation) NPC in fresh-frozen and paraffin wax embedded brain tissue are described. Advice on how to label these NPC is also offered and multi-label fluorescence immunochemical staining approaches to determine the differentiation fate of NPC are described.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Key words:</Heading>
              <Keyword>Bromodeoxyuridine</Keyword>
              <Keyword>Neural progenitor cells</Keyword>
              <Keyword>Immunohistochemistry</Keyword>
              <Keyword>Immunofluoresence</Keyword>
              <Keyword>Brain</Keyword>
              <Keyword>Neurogenesis</Keyword>
              <Keyword>Gliogenesis</Keyword>
              <Keyword>Fresh-frozen</Keyword>
              <Keyword>Paraffin embedded</Keyword>
            </KeywordGroup>
          </ChapterHeader>
          <Body>
            <Section1 ID="Sec1_15">
              <Heading>Introduction</Heading>
              <Para>This chapter highlights the most common approaches to identify progenitor and stem cells in the adult brain. The techniques include the identification of endogenous neural progenitor cells (NPC) (sometimes referred to in the literature as multi-potent stem cells or neural precursor cells) and exogenous progenitor/stem cells that have been introduced into the brain (e.g. via transplantation).</Para>
              <Para>The production of new neurons (neurogenesis) and glial cells (gliogenesis) is ongoing throughout adult life (<CitationRef CitationID="CR1_15">1</CitationRef>) In mammals there are two major areas in the brain where new cells (referred to here as NPC) are produced. These are the sub-ventricular zone of the lateral ventricles (SVZ) and the sub-granular zone of the dentate gyrus (SGZ). New cells from the SVZ migrate to the olfactory bulb (via the rostral migratory stream, RMS) (<CitationRef CitationID="CR2_15">2</CitationRef>) while new cells from the SGZ integrate into the local hippocampal network (<CitationRef CitationID="CR3_15">3</CitationRef>).</Para>
              <Para>Exogenous NPC can be delivered to the brain via several different routes, including direct injection (transplant) or indirectly, such as, via tail-vein infusion. The ability to locate these cells after delivery is an essential part of any study of transplanted NPC. Locating same species NPC transplant offers several technical challenges whereas xenotransplant (e.g. human NPC into mouse) can often prove simpler.</Para>
            </Section1>
            <Section1 ID="Sec2_15">
              <Heading>Materials</Heading>
              <Section2 ID="Sec3_15">
                <Heading>Preparing Brain Tissue (Frozen and Paraffin Wax Embedded)</Heading>
                <Section3 ID="Sec4_15">
                  <Heading>Common Items</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Phosphate buffered saline (PBS, 1×), pH 7.4.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Fresh paraformaldehyde (PFA, 4% w/v in PBS, 1×), pH 7.4 (Fisher Scientific, UK).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Dry ice.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Isopentane (aka, methylbutane or 2-methylbutane) (Sigma-Aldrich, UK).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Sucrose/PFA (20% sucrose w/v in PFA 4% w/v) (Melford, UK).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>OCT embedding compound (Raymond Lamb, UK).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Cryostat to cut sections at 15–40 μm.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Frozen section storage media (<Emphasis Type="Italic">see</Emphasis> below).<Table Float="Yes" ID="Tab1">
                              <tgroup cols="4">
                                <colspec colname="c0" colnum="0"/>
                                <colspec colname="c1" colnum="1"/>
                                <colspec colname="c2" colnum="2"/>
                                <colspec colname="c3" colnum="3"/>
                                <tbody>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Should be used at pH 7.4</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>500 ml</SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1 l</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>2 l</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Ethylene glycol</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>150 ml</SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>300 ml</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>600 ml</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Glycerol</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>100 ml</SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>200 ml</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>400 ml</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>0.2 M Na<Subscript>2</Subscript>HPO<Subscript>4</Subscript> stock</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>101 ml</SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>202 ml</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>404 ml</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>0.2 M NaH<Subscript>2</Subscript>PO<Subscript>4</Subscript>·stock</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>24 ml</SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>48 ml</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>96 ml</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>dH<Subscript>2</Subscript>O</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>125 ml</SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>250 ml</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>500 ml</SimplePara>
                                    </entry>
                                  </row>
                                </tbody>
                              </tgroup>
                            </Table>
                          </Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Serial ethanol concentrations (50, 70, 90, 95 made up in distilled water and 100%) (Fisher Scientific, UK).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Xylene solutions (1:1 with 100% ethanol, 100% xylene) (Cellpath, UK).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>11.</ItemNumber>
                        <ItemContent>
                          <Para>Paraffin wax (liquid form in heating chamber above 60°C) (Raymond Lamb, UK).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>12.</ItemNumber>
                        <ItemContent>
                          <Para>Embedding cassettes and moulds (Raymond Lamb, UK).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec6_15">
                <Heading>BrdU Labelling (In Vivo and In Vitro)</Heading>
                <Section3 ID="Sec7_15">
                  <Heading>In Vivo</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>BrdU, concentrations used vary by system and model being studied, typically a range of 10–200 mg/kg dissolved in sterile saline (NaCl) are used for animal injections. Make sure the volume delivered to the rat/mouse is around 0.5–1.0 ml (Sigma-Aldrich, UK).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Sterile syringe and needle (try to use as small a gauge and possible &lt;25) (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_15">1</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec8_15">
                  <Heading>In Vitro</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>BrdU doses historically range from 1 to 10 μM (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_15">2</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec9_15">
                <Heading>Immunohistochemistry (Chromogen-Based and Fluorescence)</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Superfrost ++ glass slides (<Emphasis Type="Italic">for on-slide staining</Emphasis>) (VWR International, UK) OR a tissue culture plate, 12- or 24-well (Nunc, Denmark) (<Emphasis Type="Italic">for free-floating section staining</Emphasis>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>PBS (1×, pH 7.4).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Triton X100 (0.05–0.5%, in PBS 1×) (Sigma-Aldrich, UK).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Blocking solution (5–10% normal serum made up in PBS) (VectorLabs, CA, USA) (<Emphasis Type="Italic">the blocker varies with the source of the antibodies being used- details in Methods section</Emphasis>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Primary antibodies.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Secondary antibodies.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Glass coverslips (<Emphasis Type="Italic">size depends on dimensions of stained sample</Emphasis>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Small paint brush.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>Large weigh boats.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para>Hydrogen peroxide (H<Subscript>2</Subscript>O<Subscript>2</Subscript>, 1–3% solution made up in ddH<Subscript>2</Subscript>O) (Sigma-Aldrich, UK).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>11.</ItemNumber>
                      <ItemContent>
                        <Para>Avidin-Biotin Complex (ABC) <Emphasis Type="Italic">Elite</Emphasis> kit (VectorLabs, CA, USA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>12.</ItemNumber>
                      <ItemContent>
                        <Para>Chromogen visualisation kit – Diaminobenzidine (DAB) or NovaRed (VectorLabs, CA, USA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>13.</ItemNumber>
                      <ItemContent>
                        <Para>Haematoxylin for counterstain (VectorLabs, CA, USA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>14.</ItemNumber>
                      <ItemContent>
                        <Para>Serial ethanol concentrations (70, 90, 95 made up in distilled water and 100%).<Footnote ID="Fn1_15">
                            <Para>Denotes optional – these can be replaced by allowing sections to air dry.</Para>
                          </Footnote>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>15.</ItemNumber>
                      <ItemContent>
                        <Para>Xylene solutions (1:1 with 100% ethanol, 100% xylene).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>16.</ItemNumber>
                      <ItemContent>
                        <Para>DPX mounting medium.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>17.</ItemNumber>
                      <ItemContent>
                        <Para>Fluorescence-conjugated secondary antibody (typically Cy-2, Cy-3, or Cy-5-conjugated AffiniPure IgG (H + L) (Jackson ImmunoResearch laboratories, Inc., USA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>18.</ItemNumber>
                      <ItemContent>
                        <Para>Rat monoclonal anti-BrdU from Oxford Biotechnology, UK, cat# OBT0030CX.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>19.</ItemNumber>
                      <ItemContent>
                        <Para>4′,6-diamidino-2-phenylindole (DAPI) 1:25,000 in PBS (1×) (Invitrogen, UK).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>20.</ItemNumber>
                      <ItemContent>
                        <Para>Vectashield mounting medium (which may contain DAPI or propidium iodide) (VectorLabs, CA, USA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>21.</ItemNumber>
                      <ItemContent>
                        <Para>Nail varnish (Clear, to seal coverslip).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec10_15">
              <Heading>Methods</Heading>
              <Para>Pre-transplant NPC and those in the brain can be labelled by addition of <Superscript>3</Superscript>[H]-thymidine which would substitute for thymidine during cell division. This technique is often ignored nowadays in favour of 5-Bromo-2′-deoxyuridine (BrdU) labelling. BrdU is a thymidine analogue and is incorporated into the DNA of dividing cells during S-phase. It can be delivered by intraperitoneal injection into the animal or added to the culture media of NPC. BrdU has limitations (at high concentrations it can be toxic and can influence cell differentiation) but it remains a popular way of detecting dividing cells in the brain (and labelling pre-transplant NPC). There are two major reasons for this. First, delivery is relatively easy and can be adjusted simply. Second, it can be detected immunohistochemically. This means that once these cells have been identified as BrdU positive they can be targeted with other markers of cell lineage to determine the phenotypic fate of the NPC (or indeed whether it was an NPC to begin with). <Emphasis Type="Bold">Table</Emphasis>
                <InternalRef RefID="Tab2">1</InternalRef> highlights many of the common antibodies used today as phenotypic markers in NPC studies. Two antibodies that can be used to directly detect dividing cells in the brain, Ki67 and proliferating cell nuclei antibody (PCNA), are also highlighted there.<Table Float="Yes" ID="Tab2">
                  <Caption Language="En">
                    <CaptionNumber>Table 1</CaptionNumber>
                    <CaptionContent>
                      <SimplePara>Commonly used antibodies to identify proliferating cells and their phenotype</SimplePara>
                    </CaptionContent>
                  </Caption>
                  <tgroup cols="4">
                    <colspec colname="c0" colnum="0"/>
                    <colspec colname="c1" colnum="1"/>
                    <colspec colname="c2" colnum="2"/>
                    <colspec colname="c3" colnum="3"/>
                    <thead>
                      <row>
                        <entry colname="c0">
                          <SimplePara>Cell type</SimplePara>
                        </entry>
                        <entry colname="c1">
                          <SimplePara>Antibody</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Comments</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>Reference</SimplePara>
                        </entry>
                      </row>
                    </thead>
                    <tbody>
                      <row>
                        <entry colname="c0">
                          <SimplePara>Proliferating</SimplePara>
                        </entry>
                        <entry colname="c1">
                          <SimplePara>BrdU</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Incorporates into proliferating cells DNA (S-phase)</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR4_15">4</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0"/>
                        <entry colname="c1">
                          <SimplePara>Ki67</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Found in all active phases of the cell cycle but is absent in the resting phase (G0)</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR5_15">5</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0"/>
                        <entry colname="c1">
                          <SimplePara>PCNA</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Proliferating cell nuclei antibody, expressed in the nuclei of actively dividing cells (S-phase)</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR6_15">6</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0">
                          <SimplePara>Neural progenitors</SimplePara>
                        </entry>
                        <entry colname="c1">
                          <SimplePara>Nestin</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Cytoskeletal protein expressed in the axons of neurons and NPCs</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR7_15">7</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0"/>
                        <entry colname="c1">
                          <SimplePara>CD133</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Glyocprotein expressed on the cell surface of NPC and glial stem cells</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR8_15">8</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0"/>
                        <entry colname="c1">
                          <SimplePara>Nucleostemin</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Nuclear protein found in NPC</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR9_15">9</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0"/>
                        <entry colname="c1">
                          <SimplePara>Sox1</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Early neuroectodermal marker. Expressed by NPCs</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR10_15">10</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0"/>
                        <entry colname="c1">
                          <SimplePara>Sox2</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Earliest neuroectodermal marker to be expressed, maintains neural progenitor characteristics</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR10_15">10</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0">
                          <SimplePara>Neurons</SimplePara>
                        </entry>
                        <entry colname="c1">
                          <SimplePara>β III tubulin</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Type 111 intermediate filament protein</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR11_15">11</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0"/>
                        <entry colname="c1">
                          <SimplePara>NeuN</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Mature neuronal nuclear protein</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR12_15">12</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0"/>
                        <entry colname="c1">
                          <SimplePara>MAP2</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Microtubule associated protein</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR13_15">13</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0"/>
                        <entry colname="c1">
                          <SimplePara>Synapsin</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Neuronal phosphoproteins associated with cytoplasmic surface of synaptic vesicles</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR14_15">14</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                      <row>
                        <entry colname="c0">
                          <SimplePara>Human</SimplePara>
                        </entry>
                        <entry colname="c1">
                          <SimplePara>Human nuclei</SimplePara>
                        </entry>
                        <entry colname="c2">
                          <SimplePara>Labels human cell nucleus</SimplePara>
                        </entry>
                        <entry colname="c3">
                          <SimplePara>
(<CitationRef CitationID="CR15_15">15</CitationRef>)
</SimplePara>
                        </entry>
                      </row>
                    </tbody>
                  </tgroup>
                </Table>
              </Para>
              <Para>Detecting NPC delivered into the host brain can be a relatively straightforward affair when cells from one species are infused into another. Probably the most common occurrence of this is when human NPC are delivered into rodent brain. Several good anti-human-cell-specific antibodies are available commercially for this approach. These in turn can be combined with phenotype markers to determine transplanted NPC fate. Identifying NPC from the same species (i.e. mouse NPC into mouse) can be somewhat more problematic. In this instance, it is common for the NPC being transplanted to be labelled in vitro prior to delivery. BrdU and <Superscript>3</Superscript>[H]-thymidine have been used for this approach with some success. Transduction (with viral vectors) and transfection of these pre-transplant NPC with reporter (marker) genes (such as EGFP) can also be used. There are limitations with each of these approaches. BrdU can have toxic effects and, like some viral vector and transfection paradigms, if the NPC continue to divide the label can become dilute. Moreover, there is some evidence that expression of some reporter transgenes in these systems can be suppressed, negating their utility.</Para>
              <Para>The development of more sophisticated viral vectors (which enable long-term, NPC-promoter-specific reporter gene expression) is a recent way of identifying these cells (endogenous and exogenous). Moreover, transgenic mice which express EGFP under the control of the largely NPC-promoter-specific Nestin have also been generated to investigate the fate of these cells in vivo. These techniques require highly specialised training and are not available to all NPC researchers and will not be discussed further in this chapter.</Para>
              <Section2 ID="Sec11_15">
                <Heading>Collecting and Processing Brains for Frozen and Wax Sectioning</Heading>
                <Section3 ID="Sec12_15">
                  <Heading>Fixation</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Terminally anaesthetise or kill the animal and immediately transcardially perfuse with chilled PBS (1×) followed by chilled PFA (4%). A peristaltic pump is the best way to do this. For standard sized rats (250–450 g) perfuse at least 150 ml of PBS and 250 ml of PFA. For standard size mice (22–40 g) perfuse at least 40 ml of PBS and 50 ml of PFA. Adjust volumes accordingly for larger/smaller rodents.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Remove the head and post-fix in PFA (4%) overnight at 4°C.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Carefully remove the brain and trim as appropriate for freezing or paraffin wax-embedding.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec13_15">
                  <Heading>Paraffin Wax Processing and Sectioning</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Although an entire mouse or rat brain can be treated for wax embedding if a vacuum embedder is used we cut our brains into blocks containing our regions of interest (e.g. sub-ventricular zone, dentate gyrus, olfactory bulb). <Emphasis Type="Italic">If no embedder is available this process can be carried-out manually on these smaller blocks of tissue</Emphasis> (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_15">3</InternalRef> for details)<Emphasis Type="Italic">.</Emphasis>
                          </Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Using a brain matrix cut the brain into the appropriate blocks containing the area of brain you want to stain. We typically cut coronal blocks of around 4–6 mm.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Place these blocks into tissue processing cassettes and put back into PFA until they are ready to be processed.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>In our case we use the standard processing and embedding cycle used in our hospital histopathology labs. In brief, the brains are washed in running water and then inserted into the chamber of the processing machine. Under vacuum they are then run through graded ethanols and xylenes before being impregnated with paraffin wax.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>The wax impregnated blocks are then put in molten wax in a mould and placed on a cold-plate until the wax hardens (any cold surface can be used for this step).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>The wax blocks can then be sectioned on a standard microtome. We collect sections of 7-μm thickness.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>These sections are cut in ribbons (ideally 9–12 sections) and placed delicately on the surface of the water in a bath set at ∼45°C until the sections flatten out completely. The wax between the sections is broken using fine-tipped forceps and the sections collected onto Superfrost ++ glass slides.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Excess water should be removed from under the sections by tapping the end of the slide on the bench.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Put the slides into a staining rack and place them on a hot-plate set at no more than 45°C until dry. Once dry store the sections in a dust-proof container at room temperature until ready for staining.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec14_15">
                  <Heading>Frozen Brain Processing and Sectioning</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>To reduce ice-crystal artefact on brain slices the brain must be cryo-protected. Place the brain into at least 40 ml of chilled sucrose/PFA (20% sucrose w/v in PFA 4% w/v) and store at 4°C. The brain will initially float in this mixture and as the sucrose replaces water in the tissue it will drop to the bottom of the container. When the brain sinks (normally 1–2 days), proceed.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Pour some isopentane (100–500 ml, depending on number of brains to freeze) into a metal beaker and place on dry-ice. Chill the liquid to ∼−42°C and immerse the brain in there for 5–10 min. The brain can now be mounted for sectioning (described below) or stored (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_15">4</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Some cryostats have rapid freezing areas for brain mounting. We prefer to mount the brain using powdered dry-ice. Mounting the brain should be done quickly and precisely. Place the cryostat chuck into the dry-ice (for 20 s) to chill it down and cover the surface with OCT mounting media. As the OCT solution turns white (freezes) place your brain in it in the orientation you desire and keep it chilled on dry-ice. The OCT should set around the area of brain submerged in it.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>The chuck (with brain attached) should now be placed into the cryostat and the temperature allowed to equilibrate (the brain will be significantly colder than the air in the cryostat) before sectioning should commence (to avoid fracture of the tissue).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Sections can now be collected directly onto Superfrost + + glass slides or placed into a tissue culture dish containing storage media (remains liquid at −20°C). For sections placed directly onto glass slides we cut at 20 μm, for free-floating sections we cut at 40 μm.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Store sections appropriately until required for staining.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec15_15">
                <Heading>Chromogen-Based BrdU Immunohistochemistry</Heading>
                <Para>All steps are carried out at room temperature unless stated otherwise.</Para>
                <Section3 ID="Sec16_15">
                  <Heading>Pre-Treatment of Wax Sections</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Remove wax from tissue by placing slides into a rack and immersing in fresh xylene – 2 × 15 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Put slides into a 1:1 mixture of xylene and ethanol (100%) 1 × 15 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Rehydrate sections through graded ethanols – 100% (2 × 5 min), 95%, 70% and 50% (1 × 5 min).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Wash slides in running tap water for 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Wash slides in PBS – 2 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Wash slides in PBS<Superscript>++</Superscript> (which is PBS with 0.3% TX100 v/v) – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec17_15">
                  <Heading>Pre-Treatment of Frozen Sections</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Remove frozen sections from freezer and allow them to equilibrate to room temperature.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Wash with PBS – 2 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Wash with PBS<Superscript>++</Superscript> (which is PBS with 0.3% TX100 v/v) – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec18_15">
                  <Heading>Common Pre-Treatment Steps</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>To quench endogenous peroxidase activity, immerse the sections in hydrogen peroxide (3% in PBS<Superscript>++</Superscript>) for 20 min. On frozen sections, particularly free-floating sections, you should see formation of small bubbles as the quenching takes place.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Wash with PBS<Superscript>++</Superscript> 3 × 5 min (making sure that all of the bubbles have been removed, wash again until this is achieved).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Wash with sodium chloride (0.9%) – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Immerse sections in 2 M hydrochloric acid (HCl) for 10 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Immerse sections in 3 M HCl for 30 min at 37°C (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_15">5</InternalRef> for further details).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Wash sections thoroughly with PBS<Superscript>++</Superscript> – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec19_15">
                  <Heading>Blocking and Antibody Steps</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Block sections with normal goat serum (10% in PBS) – 1 h.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>After removing blocker, add primary antibody against BrdU and incubate overnight at 4°C. End user should determine antibody dilution to be used depending upon their sample conditions (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_15">6</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Retrieve primary antibody for re-use (generally this can be used a few times – make sure to test this on non-essential samples first).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Wash sections with PBS – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Add secondary antibody, anti-rat IgG (1:200 dilution in PBS) for 1 h. <Emphasis Type="Italic">After 40 min prepare the ABC solution for use later.</Emphasis>
                          </Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Remove secondary antibody and wash with PBS − 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Incubate with ABC solution for 1 h.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Wash with PBS – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Add chromogen of choice according to manufacturers’ instructions. We use either diaminobenzidene (DAB) or NovaRed kits from VectorLabs. In short, the solutions are mixed together and the sections incubated for up to 8 min – until positive staining can be seen under a microscope (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_15">7</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Wash sections thoroughly with water to stop peroxidase reaction (1 × 5 min).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>11.</ItemNumber>
                        <ItemContent>
                          <Para>At this point the sections need to be dehydrated (or mounted onto slides and dehydrated if free-floating section have been used – see below for mounting instructions)</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>12.</ItemNumber>
                        <ItemContent>
                          <Para>To dehydrate the sections they can simply be left in a slide rack to dry at room temperature or they can be run through graded ethanols and xylene (i.e. repeat <Emphasis Type="Bold">steps 3, 2</Emphasis> and <Emphasis Type="Bold">1</Emphasis> of this protocol – in that order) and coverslipped using DPX.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec20_15">
                  <Heading>Mounting Free-Floating Sections onto Slides</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Lift stained sections using a fine paint brush and place into a suitable receptacle (we use a large plastic weigh boat on a black card surface – to increase contrast) filled with PBS. To reduce surface tension put a tiny drop of Triton-X100 into the PBS (∼2 μl).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Dip your glass slide into the PBS and use your paint brush to drag your section across the slide and flatten it out. Repeat as necessary and allow the sections to air dry.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Once dry, the sections should be dipped into xylene and coverslipped using DPX.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec21_15">
                  <Heading>Counterstaining</Heading>
                  <Para>To put the BrdU labelled cells into context it is often useful to counterstain your sections. This should be done prior to the dehydration step for sections already on glass slides and after dehydration of free-floating sections that have been mounted onto slides. Several counterstains are available; we use haematoxylin. The idea of a counterstain is to very lightly label the cells in your sections to help identify structures without drowning out the immunoreactive cells (in this case BrdU positive cells) (<Emphasis Type="Italic">see</Emphasis>
                    <Emphasis Type="Bold">Note</Emphasis>
                    <InternalRef RefID="Sec31_15">8</InternalRef>).
<OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>As the haematoxylin is water based, the sections must be hydrated. Those on glass slides can be used immediately, those dried following mounting onto slides need to be rehydrated through graded ethanols back into water (<Emphasis Type="Bold">steps 2–4</Emphasis> of this protocol).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Put sections into haematoxylin for 20 s, immediately wash in running tap water and observe staining under a microscope. Continue this process until a good, light stain is observed (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_15">9</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>When you are happy with the stain (it should be slightly darker than you want it to be in the end) wash the sections in running tap water for 2 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>If the staining is a bit strong you can differentiate it by dipping into hydrochloric acid (1%) in methanol. Each dip will reduce the level of haematoxylin stain (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_15">10</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Once a suitable counterstain has been achieved, dehydrate the sections through graded ethanols and xylene as described in <Emphasis Type="Bold">steps 3, 2</Emphasis> and <Emphasis Type="Bold">1</Emphasis>.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Coverslip sections using DPX.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>When DPX is dry, sections can be viewed using a light microscope.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec22_15">
                <Heading>Fluorescence-Based BrdU Immunohistochemistry</Heading>
                <Para>We rarely use fluorescence labelling for wax sections, it does, however, have the advantage of requiring fewer steps and allows for cells to be labelled with more than one antibody.</Para>
                <Section3 ID="Sec23_15">
                  <Heading>Pre-Treatment of Wax Sections</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Remove wax from tissue by placing slides into a rack and immersing in fresh xylene – 2 × 15 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Put slides into a 1:1 mixture of xylene and ethanol (100%) 1 × 15 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Rehydrate sections through graded ethanols – 100% (2 × 5 min), 95%, 70% and 50% (1 × 5 min).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Wash slides in running tap water for 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Wash slides in PBS – 2 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Wash slides in PBS<Superscript>++</Superscript> (which is PBS with 0.3% TX100 v/v) – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec24_15">
                  <Heading>Pre-Treatment of Frozen Sections</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Remove frozen sections from freezer and allow them to equilibrate to room temperature.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Wash with PBS – 2 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Wash with PBS<Superscript>++</Superscript> (which is PBS with 0.3% TX100 v/v) – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec25_15">
                  <Heading>Common Pre-Treatment Steps</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Wash with sodium chloride (NaCl, 0.9%) – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Immerse sections in 2 M hydrochloric acid (HCl) for 10 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Immerse sections in 3 M HCl for 30 min at 37<Superscript>0</Superscript>C.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Wash sections thoroughly with PBS<Superscript>++</Superscript> – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec26_15">
                  <Heading>Blocking and Antibody Steps</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Block sections with normal donkey serum (5% in PBS) 1 h.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>After removing blocker, add primary antibody against BrdU (Rat monoclonal anti-BrdU from Abcam, cat# ab6326) and incubate overnight at 4°C. End user should determine antibody dilution to be used depending upon their sample conditions (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_15">6</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Retrieve primary antibody for re-use (generally this can be used a few times – make sure to test this on non-essential samples first).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Wash sections with PBS – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Add secondary antibody, donkey anti-rat IgG with Cy3 conjugated (1:400 dilution in PBS) for 1 h.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Remove secondary antibody and wash with PBS – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>At this point cell nuclei can be labelled by washing with DAPI in PBS (1:25,000 dilution) for 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Remove DAPI and wash with PBS – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>At this point the sections should be kept “wet” and either mounted onto slides (if not already on slides) and coverslipped using Vectashield – if no further labels are to be added.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>If you wish to probe with further antibodies (e.g. lineage markers – neuronal or glial) then immerse the sections in PFA for 20 min and follow the protocol in <Emphasis Type="Bold">Subheading</Emphasis>
                            <InternalRef RefID="Sec27_15">3.4</InternalRef>, <Emphasis Type="Bold">step 2</Emphasis>.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec27_15">
                <Heading>Multi-label Fluorescence Staining to Determine NPC Phenotype</Heading>
                <Para>As outlined above NPC loaded (in vivo or in vitro) with BrdU can be detected immunohistochemically. BrdU, however, is not an NPC specific marker (neither are Ki67 nor PCNA which can also be used). They will detect all dividing cells. This type of labelling is adequate where the experiment is designed to show an overall increase or decrease in cell proliferation in the brain, but is inadequate to determine if NPC alone are altered. To do this, one must use multi-label fluorescence to identify the phenotype of BrdU labelled cells.</Para>
                <Para>We typically use 40-μm thick, free-floating frozen sections for this approach, although slide mounted frozen and wax sections can also be used. The protocol below describes our standard triple-label approach for BrdU (or Ki67) with β III tubulin (Tuj1 antibody) and GFAP.</Para>
                <Section3 ID="Sec28_15">
                  <Heading>Pre-Treatment of Frozen Sections</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Remove frozen sections from freezer and allow them to equilibrate to room temperature or if continuing with BrdU stained sections remove PFA.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Wash with PBS – 2 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Wash with PBS<Superscript>++</Superscript> (which is PBS with 0.1% TX100 v/v) – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec29_15">
                  <Heading>Blocking and Antibody Steps</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Block sections with normal donkey serum (5% in PBS) – 1 h.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>After removing blocker, add primary antibodies against β III tubulin (we use mouse monoclonal anti-β III tubulin from Abcam.com, cat# ab14545) and GFAP (guinea pig polyclonal anti-GFAP from Advanced ImmunoChemicals, cat# 31223) incubate overnight at 4°C. End user should determine the optimum antibody dilution to be used for their sample conditions (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_15">11</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Retrieve primary antibody for re-use (generally these can be used a few times – make sure to test this on non-essential samples first).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Wash sections with PBS – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Add secondary antibodies, donkey anti-mouse IgG with Cy2 conjugated and donkey anti-guinea pig with Cy5 conjugated (each at 1:400 dilution in PBS) for 1 h.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Remove secondary antibody and wash with PBS – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>At this point, cell nuclei can be labelled by washing with DAPI in PBS (1:25,000 dilution) for 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Remove DAPI and wash with PBS – 3 × 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Keep the sections “wet” and mount onto slides.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Coverslip using Vectashield.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>11.</ItemNumber>
                        <ItemContent>
                          <Para>To prevent drying of the sections and loss of staining it is prudent to secure the coverslip over the sections using clear nail varnish.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>12.</ItemNumber>
                        <ItemContent>
                          <Para>Once dried the sections can be viewed under a fluorescence microscope with a tungsten light source and filters for green, red, far red and dapi. Do this for a very short time (seconds) just to check that the staining has worked.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>13.</ItemNumber>
                        <ItemContent>
                          <Para>If the staining has worked, the sections should be stored in a cool dark place until they can be viewed on a confocal microscope.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>14.</ItemNumber>
                        <ItemContent>
                          <Para>The confocal microscope must have excitation lasers to stimulate dapi (364 nm) for blue emission (454 nm), Cy2 (492 nm) for green emission (510 nm), Cy3 (550 nm) for red emission (570 nm) and Cy5 (650 nm) for far red emission (670 nm).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec30_15">
                <Heading>Detecting Transplanted NPC</Heading>
                <Para>As mentioned earlier in the text, generally speaking, there are two scenarios here. Xenotransplant and same species transplant. We commonly detect human NPC in rodent brain using the same protocols already outlined in <Emphasis Type="Bold">Subheading</Emphasis>
                  <InternalRef RefID="Sec15_15">3.2</InternalRef>–<InternalRef RefID="Sec27_15">3.4</InternalRef>, the only differences being the primary antibody and blocking sera used. To stain for human cells we use anti-human nuclei antibody (from Chemicon, USA) 1:50 dilution in PBS and normal horse serum for chromogen-based staining. In order to detect same species (i.e. mouse NPC in mouse brain) pre-transplant labelling is required. Depending upon the labelling techniques employed, these cells can then be detected as described in <Emphasis Type="Bold">Subheading</Emphasis>
                  <InternalRef RefID="Sec15_15">3.2</InternalRef>–<InternalRef RefID="Sec27_15">3.4</InternalRef> using antibodies directed at it, for example, BrdU.</Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec31_15">
              <Heading>Notes</Heading>
              <Para>
                <OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para>Smaller diameter needles cause less damage during repeated injections. Sometimes injections are required several times a day or daily over several days. We have found that syringes with fixed needles designed for daily insulin delivery for diabetics work well.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para>A recent paper (<CitationRef CitationID="CR16_15">16</CitationRef>) suggests that 0.2 μM is a more effective dose.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para>Wax embedding by hand (for small volumes of tissue): (a) Cut PFA (4%) fixed tissue into small blocks and place into tissue embedding cassettes and immerse cassettes in the following solutions in order; (b) Running water for at least 30 min; (c) 70% Ethanol, 2 × 30 min; (d) 90% Ethanol, 2 × 30 min; (e) 100% Ethanol, 2 × 30 min; (f) 100% Ethanol/Xylene (1:1), 30 min; (g) Xylene, 2 × 30 min; (h) Molten paraffin wax (60°C), 1 h; (i) Molten paraffin wax (60°C), overnight; (j) At this point follow <Emphasis Type="Bold">steps 8–12</Emphasis> of <Emphasis Type="Bold">Subheading</Emphasis>
                        <InternalRef RefID="Sec11_15">3.1</InternalRef>.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para>To store the brain and avoid freezerburn, wrap it in Parafilm, place in a small sealable bag, put in a closable container (like a 50 ml Falcon tube); and store until needed at −80°C.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para>These steps may be lengthened or shortened depending upon the condition of the tissue being stained and the age of the HCl. Ideally “fuming” acid should be used. Moreover, the acid steps are often followed by immersing the sections in borate buffer. This is an optional step which we do not always use. We generally use generous PBS washes.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para>As reference for 7-μm wax sections we use 1:200 dilution (in PBS) for 40-μm frozen sections we use 1:250.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>7.</ItemNumber>
                    <ItemContent>
                      <Para>By stopping the reaction with water on a test section every minute or so to check staining level the precise incubation time for your sample can be determined for the remaining sections.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>8.</ItemNumber>
                    <ItemContent>
                      <Para>If your BrdU labelling is very faint counterstaining is best avoided.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>9.</ItemNumber>
                    <ItemContent>
                      <Para>This step is completely end-user dependent as differently processed tissues and different haematoxylin mixtures (including older solutions vs. fresh solutions) vary from lab to lab. It may be the case that you can increase the amount of time between each observation of the staining.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>10.</ItemNumber>
                    <ItemContent>
                      <Para>Take care after this treatment to get the sections back into running tap water swiftly to avoid excessive destaining. If too much stain is removed – repeat from <Emphasis Type="Bold">step 2</Emphasis> in Section 3.2.6.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>11.</ItemNumber>
                    <ItemContent>
                      <Para>As reference for 7-μm wax sections we use β-tubulin III at 1:600 and GFAP at 1:300 dilutions in PBS. For 40-μm frozen sections we use β-tubulin III at 1:1,000 and GFAP at 1:500 dilutions in PBS.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/978-1-60327-931-4_Chapter_15.pdf" OutputMedium="Online" PDFType="Typeset" TargetType="OnlinePDF"/>
          <ChapterBackmatter>
            <Bibliography ID="Bib1_15">
              <Heading>References</Heading>
              <Citation ID="CR1_15">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E.</Initials>
                    <FamilyName>Gould</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">How widespread is adult neurogenesis in mammals?</ArticleTitle>
                  <JournalTitle>Nat Rev Neurosci</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>481</FirstPage>
                  <LastPage>8</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17514200</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nrn2147</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2sXlsVSktb8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gould, E. (2007). How widespread is adult neurogenesis in mammals? Nat Rev Neurosci, 8: 481–8.</BibUnstructured>
              </Citation>
              <Citation ID="CR2_15">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.A.</Initials>
                    <FamilyName>Curtis</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>315</VolumeID>
                  <IssueID>5816</IssueID>
                  <FirstPage>1243</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17303719</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.1136281</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2sXitFChs7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Curtis, M.A., et al (2007). Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science, 315(5816): 1243–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR3_15">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Kempermann</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Milestones of neuronal development in the adult hippocampus</ArticleTitle>
                  <JournalTitle>Trends Neurosci</JournalTitle>
                  <VolumeID>27</VolumeID>
                  <IssueID>8</IssueID>
                  <FirstPage>447</FirstPage>
                  <LastPage>52</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15271491</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.tins.2004.05.013</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmtVahtrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kempermann, G., et al (2004). Milestones of neuronal development in the adult hippocampus. Trends Neurosci, 27(8): 447–52.</BibUnstructured>
              </Citation>
              <Citation ID="CR4_15">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H.G.</Initials>
                    <FamilyName>Kuhn</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <IssueID>15</IssueID>
                  <FirstPage>5820</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9221780</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXkvFynu7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kuhn, H.G., et al (1997). Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci, 17(15): 5820–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR5_15">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Komitova</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Enriched environment increases neural stem/progenitor cell proliferation and neurogenesis in the subventricular zone of stroke-lesioned adult rats</ArticleTitle>
                  <JournalTitle>Stroke</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <IssueID>6</IssueID>
                  <FirstPage>1278</FirstPage>
                  <LastPage>82</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15879324</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1161/01.STR.0000166197.94147.59</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Komitova, M., et al (2005). Enriched environment increases neural stem/progenitor cell proliferation and neurogenesis in the subventricular zone of stroke-lesioned adult rats. Stroke, 36(6): 1278–82.</BibUnstructured>
              </Citation>
              <Citation ID="CR6_15">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Redmond</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Hockfield</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.A.</Initials>
                    <FamilyName>Morabito</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">The divergent homeobox gene PBX1 is expressed in the postnatal subventricular zone and interneurons of the olfactory bulb</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <IssueID>9</IssueID>
                  <FirstPage>2972</FirstPage>
                  <LastPage>82</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8622127</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XisFSksrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Redmond, L., S. Hockfield, and M.A. Morabito (1996). The divergent homeobox gene PBX1 is expressed in the postnatal subventricular zone and interneurons of the olfactory bulb. J Neurosci, 16(9): 2972–82.</BibUnstructured>
              </Citation>
              <Citation ID="CR7_15">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>U.</Initials>
                    <FamilyName>Lendahl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.B.</Initials>
                    <FamilyName>Zimmerman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.D.</Initials>
                    <FamilyName>McKay</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">CNS stem cells express a new class of intermediate filament protein</ArticleTitle>
                  <JournalTitle>Cell</JournalTitle>
                  <VolumeID>60</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>585</FirstPage>
                  <LastPage>95</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1689217</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0092-8674(90)90662-X</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXkvFagsro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lendahl, U., L.B. Zimmerman, and R.D. McKay (1990). CNS stem cells express a new class of intermediate filament protein. Cell, 60(4): 585–95.</BibUnstructured>
              </Citation>
              <Citation ID="CR8_15">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Uchida</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Direct isolation of human central nervous system stem cells</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>97</VolumeID>
                  <IssueID>26</IssueID>
                  <FirstPage>14720</FirstPage>
                  <LastPage>5</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11121071</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.97.26.14720</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXitVGgtg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Uchida, N., et al (2000). Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA, 97(26): 14720–5.</BibUnstructured>
              </Citation>
              <Citation ID="CR9_15">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Maki</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Rapid accumulation of nucleostemin in nucleolus during newt regeneration</ArticleTitle>
                  <JournalTitle>Dev Dyn</JournalTitle>
                  <VolumeID>236</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>941</FirstPage>
                  <LastPage>50</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17133523</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/dvdy.21027</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2sXltlWnsLo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maki, N., et al (2007). Rapid accumulation of nucleostemin in nucleolus during newt regeneration. Dev Dyn, 236(4): 941–50.</BibUnstructured>
              </Citation>
              <Citation ID="CR10_15">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V.</Initials>
                    <FamilyName>Graham</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">SOX2 functions to maintain neural progenitor identity</ArticleTitle>
                  <JournalTitle>Neuron</JournalTitle>
                  <VolumeID>39</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>749</FirstPage>
                  <LastPage>65</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12948443</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0896-6273(03)00497-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnt1Wku78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Graham, V., et al (2003). SOX2 functions to maintain neural progenitor identity. Neuron, 39(5): 749–65.</BibUnstructured>
              </Citation>
              <Citation ID="CR11_15">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C.N.</Initials>
                    <FamilyName>Svendsen</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">A new method for the rapid and long term growth of human neural precursor cells</ArticleTitle>
                  <JournalTitle>J Neurosci Methods</JournalTitle>
                  <VolumeID>85</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>141</FirstPage>
                  <LastPage>52</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9874150</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0165-0270(98)00126-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXnsFaju7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Svendsen, C.N., et al (1998). A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods, 85(2): 141–52.</BibUnstructured>
              </Citation>
              <Citation ID="CR12_15">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R.J.</Initials>
                    <FamilyName>Mullen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.R.</Initials>
                    <FamilyName>Buck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.M.</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">NeuN, a neuronal specific nuclear protein in vertebrates</ArticleTitle>
                  <JournalTitle>Development</JournalTitle>
                  <VolumeID>116</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>201</FirstPage>
                  <LastPage>11</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1483388</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXktlGi</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mullen, R.J., C.R. Buck and A.M. Smith (1992). NeuN, a neuronal specific nuclear protein in vertebrates. Development, 116(1): 201–11.</BibUnstructured>
              </Citation>
              <Citation ID="CR13_15">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F.J.</Initials>
                    <FamilyName>Diez-Guerra</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Avila</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">MAP2 phosphorylation parallels dendrite arborization in hippocampal neurons in culture</ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>419</FirstPage>
                  <LastPage>22</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8499602</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001756-199304000-00020</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXksVKit74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Diez-Guerra, F.J. and J. Avila (1993). MAP2 phosphorylation parallels dendrite arborization in hippocampal neurons in culture. Neuroreport, 4(4): 419–22.</BibUnstructured>
              </Citation>
              <Citation ID="CR14_15">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.P.</Initials>
                    <FamilyName>Rastaldi</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Glomerular podocytes contain neuron-like functional synaptic vesicles</ArticleTitle>
                  <JournalTitle>FASEB J</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <IssueID>7</IssueID>
                  <FirstPage>976</FirstPage>
                  <LastPage>8</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16585060</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1096/fj.05-4962fje</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD28XksFWhs74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rastaldi, M.P., et al (2006). Glomerular podocytes contain neuron-like functional synaptic vesicles. FASEB J, 20(7): 976–8.</BibUnstructured>
              </Citation>
              <Citation ID="CR15_15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R.A.</Initials>
                    <FamilyName>Fricker</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <IssueID>14</IssueID>
                  <FirstPage>5990</FirstPage>
                  <LastPage>6005</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10407037</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXksVyktbY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fricker, R.A., et al (1999). Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci, 19(14): 5990–6005.</BibUnstructured>
              </Citation>
              <Citation ID="CR16_15">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.A.</Initials>
                    <FamilyName>Caldwell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X.</Initials>
                    <FamilyName>He</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.N.</Initials>
                    <FamilyName>Svendsen</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">5-Bromo-2′-deoxyuridine is selectively toxic to neuronal precursors in vitro</ArticleTitle>
                  <JournalTitle>Eur J Neurosci</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <IssueID>11</IssueID>
                  <FirstPage>2965</FirstPage>
                  <LastPage>70</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16324131</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1460-9568.2005.04504.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Caldwell, M.A., X. He, and C.N. Svendsen (2005). 5-Bromo-2′-deoxyuridine is selectively toxic to neuronal precursors in vitro. Eur J Neurosci, 22(11): 2965–70.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ChapterBackmatter>
        </Chapter>
      </Part>
    </Book>
  </Series>
</Publisher>